Supplementary Materials and Methods

Antibodies
The following primary antibodies were used for western blotting: anti-GFP (Roche), antiubiquitin FK2 (Enzo), anti-NEDD8 (Epitomics), anti-CUL4B and anti-FLAG-M2 (Sigma), anti-UBCH7 (Boston Biochem), anti-CUL1 and anti-CUL2 (Invitrogen), anti-RBX (Thermo Scientific), anti-Elongin-B and anti-Elongin-C (BioLegend), anti-p27
Kip1 ,
anti-HA, and anti-β-actin (Cell Signaling Technology). Polyclonal sheep anti-TRIAD1
antibodies were generated by immunizing sheep with full-length TRIAD1 protein.
Antibodies specific for Cullin 3 were raised in sheep against .
Antibodies that recognize Cullin 4A were generated by immunizing sheep with GSTCullin 4A (573-672). Antisera specific for Cullin 5 were raised in sheep immunized against .
Gene disruption of the chicken ARIH2 locus and generation of complementation cell lines
A gene-targeting construct was designed to remove exons 4 and 5 of the chicken ARIH2 locus, thereby disrupting the N-terminal RING1 domain of the protein (Supplementary Figure S5A) . The 3′ arm of the targeting construct was amplified from chicken genomic DNA using the PCR primers AAGAATTCCAGGAACTTGTTGGCTGGTGCT- Figure S5B) and PCR screening.
To generate DT40 cell lines expressing human TRIAD1 (WT) and human TRIAD1 (C300A), the relevant constructs were subcloned first into the SmaI site of pExpress then into the SpeI site of pLoxBsr (Arakawa et al, 2001 ). These TRIAD1 transgenes were stably integrated into GgARIH2 -/-DT40 cells as described previously. An in vitro screen of 34 different E2 enzymes was carried out using Ubiquigent's E2 scan kit together with 1 μM TRIAD1. Reaction products were analyzed by immunoblotting with anti-ubiquitin antibody. Only UBCH7 showed appreciable TRIAD1-dependent activity (shown boxed in red). To allow comparison of data across multiple western blots a control reaction was performed and loaded on all gels, as indicated. This control reaction contained TRIAD1 and our own UBCH7 and UBE1 protein preparations under reaction conditions otherwise identical to those of the E2 scan kit. (B) in vitro auto-ubiquitylation reaction with 0.3 or 2.4 μM TRIAD1 and 0.6 μM UBCH7, measured at the indicated timepoints by immunoblotting with anti-ubiquitin antibody. 
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Supplementary Figure S4 HHARI associates with neddylated CRL complexes. GFP, GFP-tagged wild-type HHARI, or the RING2 mutant of HHARI containing the amino acid substitution C357S, were stably expressed in HEK293 cells and immunoprecipitated using anti-GFP agarose. The inputs and immunopellets (IP: GFP) were immunoblotted using the indicated antibodies. figure 7C , were treated for 3 hrs with 3 μM MLN4924 to completely abolish cullin neddylation. Cells were then washed to remove the inhibitor, allowed to recover in fresh medium for the indicated time periods and then whole cell lysates were subjected to immunoblot analyses with the indicated antibodies. (E) Flow cytometry cell cycle profiles of the indicated cell lines following treatment with thymidine or nocodazole. (F) The stability of the indicated GFP-HHARI constructs was analysed +/− MG132 by immunoblotting following anti-GFP immunoprecipitation. CUL2-N8, neddylated CUL2; CUL5-N8, neddylated CUL5. 
